TP53 and breast cancer: In Brazil, frequency mutations in this gene are reported in 73.3% of patients, while the founder mutation TP53 p.R337H is detected in 0.3% of the general population in southern Brazil and it is responsible for 3.4–8.6% hereditary or familiar breast cancers [51, 90].